A recent vote by an FDA advisory committee is recommending eventual FDA approval of Palforzia, a novel therapy that may be indicated for patients between 4 and 17 years with peanut allergies.
As research into eczema advances, the more allergists understand its association with other allergic diseases. Scientists have noted a phenomenon coined the “atopic march”, which is an observed progression where infants who have eczema may develop food allergies, asthma and environmental allergies later in life.
New Research Suggests that Patients Who Undergo Oral Immunotherapy For Egg Allergy Tolerate Egg After 5 Years
New research that was recently presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) suggests that certain patients with egg allergy treated with oral immunotherapy (OIT) tolerated egg 5 years later.
Data from Phase II Trial on Investigational Oral Asthma Medication Show Promise by Targeting Airway Muscles
In the latest issue of Science Translational Medicine, researchers from the U.K. demonstrated positive results in the treatment of asthma with a new oral medication